title: Prevention and treatment of graft vessel disease after heart transplantation.
authors.affiliation: Department of Cardiac Surgery and Clinical Chemistry, Ludwig-Maximilians-University Munich, Grosshadern Medical Center, Germany.
authors.forename: B M
authors.initials: BM
authors.lastname: Meiser
authors.forename: K
authors.initials: K
authors.lastname: Wenke
authors.forename: J
authors.initials: J
authors.lastname: Thiery
authors.forename: U
authors.initials: U
authors.lastname: Brandl
authors.forename: H
authors.initials: H
authors.lastname: Mair
authors.forename: F
authors.initials: F
authors.lastname: Kur
authors.forename: C
authors.initials: C
authors.lastname: Detter
authors.forename: P
authors.initials: P
authors.lastname: Uberfuhr
authors.forename: E
authors.initials: E
authors.lastname: Kreuzer
authors.forename: D
authors.initials: D
authors.lastname: Seidel
mesh_terms: D000328:Adult; D001161:Arteriosclerosis / Q000517:prevention & control* / Q000628:therapy*; D001781:Blood Component Removal; D002784:Cholesterol / Q000097:blood; D004311:Double-Blind Method; D005260:Female; D006083:Graft Occlusion, Vascular / Q000517:prevention & control* / Q000628:therapy*; D006086:Graft vs Host Disease / Q000517:prevention & control; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use*; D010456:Peptides, Cyclic; D011446:Prospective Studies; D012307:Risk Factors; D019821:Simvastatin; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014019:Tissue Donors
chemical_list: D009842:Oligopeptides; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D002784:Cholesterol; D008148:Lovastatin; D019821:Simvastatin